Related Experiment Video
Updated: May 25, 2026

Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Asthma and coagulation
J Daan de Boer1, Christof J Majoor, Cornelis van 't Veer
1Academic Medical Center,University of Amsterdam, Center for Experimental and Molecular Medicine, Meibergdreef 9, Amsterdam, The Netherlands. j.d.deboer@amc.uva.nl
Abstract:
Asthma is a chronic airway disease characterized by paroxysmal airflow obstruction evoked by irritative stimuli on a background of allergic lung inflammation. Currently, there is no cure for asthma, only symptomatic treatment. In recent years, our understanding of the involvement of coagulation and anticoagulant pathways, the fibrinolytic system, and platelets in the pathophysiology of asthma has increased considerably. Asthma is associated with a procoagulant state in the bronchoalveolar space, further aggravated by impaired local activities of the anticoagulant protein C system and fibrinolysis. Protease-activated receptors have been implicated as the molecular link between coagulation and allergic inflammation in asthma. This review summarizes current knowledge of the impact of the disturbed hemostatic balance in the lungs on asthma severity and manifestations and identifies new possible targets for asthma treatment.
Related Concept Videos
Asthma I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Anticoagulant Drugs: Low-Molecular-Weight Heparins
